Joshua Field, MD, MS is featured in an article published in the Milwaukee Journal Sentinel titled “New drug could ease pain of sickle cell disease”. The article focuses on Latoyia Webb, one of almost 100 participants in eight cities and one of 20 to 25 people in Wisconsin who are in the trial. Participants will be treated at the worst points of the blood disease, episodes called sickle cell pain crises.
Some will get standard treatment plus regadenoson, already FDA-approved, but for a different use in cardiac stress tests. Others will receive a placebo plus the standard treatment.
In Milwaukee, the clinical trial is being led by Dr. Field. Field has devoted much of his work to sickle cell disease because of people like Webb.
Dr. field is the medical director of the BloodCenter of Wisconsin, an associate professor at the Medical College of Wisconsin, and the medical director of the Adult Sickle Cell Clinic at Froedtert & The Medical College of Wisconsin.
NIH Funding Acknowledgment:Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.
